BPH - Benign Prostatic Enlargement - Results from #2820

Phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia - Abstract March 14, 2011

Major depression drives severity of American Urological Association Symptom Index - Abstract March 11, 2011

Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: Results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe - Abstract March 10, 2011

New advances in benign prostatic hyperplasia: Laser therapy - Abstract March 9, 2011

Reduced levels of 5-α reductase 2 in adult prostate tissue and implications for BPH therapy - Abstract March 8, 2011

Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A 1-year, open-label extension study - Abstract March 7, 2011

Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients - Abstract February 22, 2011

Progression of null or mild lower urinary tract symptoms indicative of benign prostatic hyperplasia after 2 years of follow-up in non-treated men aged 40 years or older - Abstract February 17, 2011

A placebo-controlled exploratory study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with storage lower urinary tract symptoms associated with a clinical diagnosis of overactive bladder March 8, 2010

Association Between T102C Polymorphism of the Serotonin Receptor 2A Gene and Urinary Incontinence Among Elderly Women June 24, 2008

BPH Guidelines April 19, 2006

Medical Management April 11, 2006

Page 142 of 142